"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases.

Published on Jul 1, 2012in Digestive and Liver Disease3.57
· DOI :10.1016/J.DLD.2011.12.019
G. Leonardi4
Estimated H-index: 4
,
Santino Marchi47
Estimated H-index: 47
+ 6 AuthorsMarco Del Chiaro31
Estimated H-index: 31
(KI: Karolinska Institutet)
Sources
Abstract
Abstract Background PancPRO is a computer program that estimates the risk of pancreatic cancer for asymptomatic individuals based on a genetic model of susceptibility and the familial incidence of cancer. Aim To evaluate the distribution of the familial risk in a series of incident cases of pancreatic adenocarcinoma. Materials and methods The lifetime risk of pancreatic cancer was calculated by PancPro for a hypothetical 40-year-old son of 570 consecutive probands with pancreatic cancer. Results The 570 risk values were included between 1% and 13%. The distribution was bimodal, with the antimode located at risk = 7.5%. Considering a 10-fold risk over the general population as a threshold for including a subject in a surveillance program, 19 families (3.3%) would be selected, totalling 92 first-degree relatives with age >40 years. Conclusions PancPro is a valid instrument to rank families based on risk of pancreatic cancer.
📖 Papers frequently viewed together
174 Citations
597 Citations
201319.82Gut
15 Authors (Marcia I. Canto, ..., Marco J. Bruno)
437 Citations
References14
Newest
#1Marco Del ChiaroH-Index: 31
#2Alessandro ZerbiH-Index: 57
Last. Massimo Falconi (University of Verona)H-Index: 105
view all 9 authors...
Abstract In Italy, pancreatic cancer is the fifth leading cause of tumor related death with about 7000 new cases per year and a mortality rate of 95%. In a recent prospective epidemiological study on the Italian population, a family history was found in about 10% of patients suffering from a ductal adenocarcinoma of the pancreas (PDAC). A position paper from the Italian Registry for Familial Pancreatic Cancer was made to manage these high-risk individuals. Even though in the majority of high-ris...
52 CitationsSource
#1William Greenhalf (University of Liverpool)H-Index: 50
#2Núria MalatsH-Index: 81
Last. John P. Neoptolemos (University of Liverpool)H-Index: 125
view all 5 authors...
Purpose: To describe the need for multinational registries of families at high risk of pancreatic cancer and the issues surrounding identification of such families. Results: A consensus position was published describing surveillance of individuals at high risk of pancreatic cancer. Hereditary pancreatitis patients, people with Peutz-Jeghers syndrome, individuals with CDKN2A or BRCA1/2 mutations with a family history of pancreatic cancer and kindred with multiple pancreatic cancers were considere...
57 CitationsSource
Background: Pancreatic cancer represents the fourth-leading cause of cancer death in the United States, with a dismal 5-year survival rate of less than 5%. Despite advancements in screening and early detection of other cancers such as breast and colon cancer, no reliable screening test exists for pancreatic cancer. Subsequently, the majority of patients present with advanced-stage disease leading to a poor prognosis. Because of the relatively low incidence, current efforts are focused on early d...
133 CitationsSource
#1Ralph H. Hruban (Johns Hopkins University)H-Index: 208
#2Anirban Maitra (Johns Hopkins University)H-Index: 136
Last. Michael Goggins (Johns Hopkins University)H-Index: 24
view all 4 authors...
Infiltrating ductal adenocarcinoma of the pancreas is believed to arise from morphologically distinct noninvasive precursor lesions. These precursors include the intraductal papillary mucinous neoplasm, the mucinous cystic neoplasm, and pancreatic intraepithelial neoplasia. Intraductal papillary mucinous neoplasms are grossly visible mucin-producing epithelial neoplasms that arise in the main pancreatic duct or one of its branches. The cysts of mucinous cystic neoplasms do not communicate with t...
221 CitationsSource
#1Marco Del Chiaro (UniPi: University of Pisa)H-Index: 31
#2Alessandro Zerbi (UniSR: Vita-Salute San Raffaele University)H-Index: 57
Last. Franco Mosca (UniPi: University of Pisa)H-Index: 58
view all 15 authors...
Background/Aims: Pancreatic cancer is a leading cause of cancer-related death; the most consistently identified risk factors are smoking and family history. Our aims were to examine
63 CitationsSource
#1Randall E. Brand (NorthShore University HealthSystem)H-Index: 71
#2Markus M. Lerch (University of Greifswald)H-Index: 102
Last. Marcia I. Canto (Johns Hopkins University)H-Index: 73
view all 9 authors...
Even with significant advances in imaging and our understanding of pancreatic cancer genetics, the survival rates for pancreatic cancer remain quite dismal. Although still at an early stage, there are efforts in place to develop surveillance and prevention strategies for people at high risk for pancreatic cancer. This comprehensive review article summarises the predispositions that put people at a high risk of developing pancreatic cancer and the current status in the counselling and surveillanc...
288 CitationsSource
#1Wenyi Wang (Johns Hopkins University)H-Index: 27
#2Sining Chen (Johns Hopkins University)H-Index: 15
Last. Alison P. Klein (Johns Hopkins University)H-Index: 67
view all 6 authors...
Purpose The rapid fatality of pancreatic cancer is, in large part, the result of an advanced stage of diagnosis for the majority of patients. Identification of individuals at high risk of developing pancreatic cancer is a first step towards the early detection of this disease. Individuals who may harbor a major pancreatic cancer susceptibility gene are one such high-risk group. The goal of this study was to develop and validate PancPRO, a Mendelian model for pancreatic cancer risk prediction in ...
174 CitationsSource
#1Rosemary D. CressH-Index: 41
#2Daixin YinH-Index: 6
Last. Elizabeth A. Holly (UCSF: University of California, San Francisco)H-Index: 87
view all 5 authors...
Objective The purpose of the current study was to evaluate survival of patients diagnosed in California with adenocarcinoma of the pancreas by demographic and tumor-related factors.
233 CitationsSource
#1Laufey T. Amundadottir (deCODE genetics)H-Index: 48
#2Sverrir Thorvaldsson (deCODE genetics)H-Index: 5
Last. Kari Stefansson (deCODE genetics)H-Index: 208
view all 11 authors...
Background The contribution of low-penetrant susceptibility variants to cancer is not clear. With the aim of searching for genetic factors that contribute to cancer at one or more sites in the body, we have analyzed familial aggregation of cancer in extended families based on all cancer cases diagnosed in Iceland over almost half a century.
309 CitationsSource
#1Sean P. Cleary (MSH: Mount Sinai Hospital, Toronto)H-Index: 34
#2Robert Gryfe (MSH: Mount Sinai Hospital, Toronto)H-Index: 21
Last. Steven Gallinger (MSH: Mount Sinai Hospital, Toronto)H-Index: 109
view all 11 authors...
Abstract Background Pancreatic cancer is a rapidly fatal disease with very few 5-year survivors even after aggressive surgical treatment. Our objective was to determine the actual 5-year survival rate of patients with pancreatic adenocarcinoma who underwent a resection with curative intent in 5 teaching hospitals within the University of Toronto system. We then sought to determine clinical and histopathologic features of 5-year survivors to determine factors associated with a favorable prognosis...
334 CitationsSource
Cited By17
Newest
#1Jean M. ChalhoubH-Index: 8
#2Sherif AndrawesH-Index: 4
Source
#1Gabriele Capurso (UniSR: Vita-Salute San Raffaele University)H-Index: 56
#2Salvatore Paiella (University of Verona)H-Index: 23
Last. Massimo FalconiH-Index: 105
view all 8 authors...
Abstract Pancreatic cancer is one of the main causes of cancer-related death worldwide, with a survival rate around 9%. In Italy 13,500 new cases of pancreatic cancer occurred in 2019. It is estimated that at least 5% have a hereditary background. Surveillance is advisable for healthy individuals with specific genetic syndromes with or without family history of pancreatic cancer or members of families with multiple cases of pancreatic cancer, irrespective of genetic syndromes. In 2010 the Italia...
Source
#1Elizabeth D. Thompson (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 20
#2Nicholas J. Roberts (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 20
Last. Ralph H. Hruban (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 208
view all 8 authors...
The publication of the “Pan-Cancer Atlas” by the Pan-Cancer Analysis of Whole Genomes Consortium, a partnership formed by The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC), provides a wonderful opportunity to reflect on where we stand in our understanding of the genetics of pancreatic cancer, as well as on the opportunities to translate this understanding to patient care. From germline variants that predispose to the development of pancreatic cancer, to somatic mut...
3 CitationsSource
#1Tanya Dwarte (Garvan Institute of Medical Research)H-Index: 1
#2Skye McKay (Garvan Institute of Medical Research)H-Index: 4
Last. Alina Stoita (St. Vincent's Health System)H-Index: 6
view all 7 authors...
Background Pancreatic cancer (PC) is an aggressive disease with a dismal 5-year survival rate. Surveillance of high-risk individuals is hoped to improve survival outcomes by detection of precursor lesions or early-stage malignancy.
2 CitationsSource
#1Jennifer L. Geurts (MCW: Medical College of Wisconsin)H-Index: 8
Pancreatic cancer (PC) is a genetically heterogenous disease with approximately 10% of cases attributed to a germline gene mutation. Family history of PC increases the risk of developing the disease two- to threefold when a single first-degree relative is affected. However, current genetic testing strategies identify a germline mutation in less than a third of suspected hereditary cases, while the remaining two-thirds or more without a causative mutation are considered to have a familial form of...
Source
#1Chad A. Barnes (MCW: Medical College of Wisconsin)H-Index: 6
#2Elizabeth A. Krzywda (MCW: Medical College of Wisconsin)H-Index: 14
Last. Susan Tsai (MCW: Medical College of Wisconsin)H-Index: 32
view all 13 authors...
Selective screening for pancreatic cancer (PC) has been proposed. We describe the establishment of a comprehensive multidisciplinary screening program using 3.0 T MRI. Criteria for screening included the presence of PC in: ≥ 2 first degree relatives (FDR), 1 FDR and 1 s degree relative (SDR), ≥ 3 any degree relatives (ADR), or any known hereditary cancer syndrome with increased PC risk. Imaging with 3.0 T MRI was performed routinely and endoscopic ultrasound was used selectively. Screening was c...
7 CitationsSource
#2Kyoichi TakaoriH-Index: 28
Last. Toru Shimosegawa (Tohoku University)H-Index: 26
view all 30 authors...
: Familial pancreatic cancer (FPC) is broadly defined as two first-degree-relatives with pancreatic cancer (PC) and accounts for 4%-10% of PC. Several genetic syndromes, including Peutz-Jeghers syndrome, hereditary pancreatitis, hereditary breast-ovarian cancer syndrome (HBOC), Lynch syndrome, and familial adenomatous polyposis (FAP), also have increased risks of PC, but the narrowest definition of FPC excludes these known syndromes. When compared with other familial tumors, proven genetic alter...
40 CitationsSource
#1Saowanee Ngamruengphong (Johns Hopkins University)H-Index: 31
#2Marcia I. Canto (Johns Hopkins University)H-Index: 73
: Pancreatic cancer (PC) is a highly fatal disease that can only be cured by complete surgical resection. However, most patients with PC have unresectable disease at the time of diagnosis, highlighting the need to detect PC and its precursor lesions earlier in asymptomatic patients. Screening is not cost-effective for population-based screening of PC. Individuals with genetic risk factors for PC based on family history or known PC-associated genetic syndromes, however, can be a potential target ...
11 CitationsSource
#1Jone E. Sampson (OHSU: Oregon Health & Science University)H-Index: 4
#2Kelly Hamman (OHSU: Oregon Health & Science University)H-Index: 4
ABSTRACTIntroduction: Genetic testing for hereditary cancer syndromes, including those with an increased risk for pancreatic cancer, has become more routine for patients and families with a personal and/or family history of cancer. Genetics professionals, including genetic counselors and medical geneticists, are specially trained to elicit and assess personal and family history, and to discuss appropriate genetic testing options and genetic test results with patients and families.Areas covered: ...
1 CitationsSource